Markus Koglin is the Senior Director of Protein Chemistry at Merck, where he leads efforts in generating purified protein for the early drug discovery pipeline. His expertise spans biophysics, pharmacology, and drug discovery, with previous leadership roles at Sosei Heptares and GlaxoSmithKline. He holds a PhD from the University of Hamburg.
He is a widely published scientific author, recognized for his significant contributions and expertise in targeting G-protein coupled receptors (GPCRs) with biologics for therapeutic use.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.